Article Data

  • Views 395
  • Dowloads 130

Case Reports

Open Access

Successful response to docetaxel treatment in recurrent ovarian granulosa cell tumor: a case report

  • T. Shavit1
  • I. BRUCHIM1,*,
  • Z. Ben-Harim1
  • A. Fishman1

1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba Israel, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

DOI: 10.12892/ejgo201204419 Vol.33,Issue 4,July 2012 pp.419-420

Published: 10 July 2012

*Corresponding Author(s): I. BRUCHIM E-mail: ilan.bruchim@gmail.com.ca

Abstract

Background: Ovarian granulosa cell tumor (GCT) is primarily treated surgically. Treatment for advanced or recurrent disease includes primary or adjuvant chemotherapy. Data about the efficacy of treatment with paclitaxel are limited, without data about the role of docetaxel in treating recurrent GCT. Case: A 68-year-old patient with Stage IA ovarian GCT diagnosed ten years earlier, presented with a third episode of recurrent disease. Following the first event of recurrent disease, she underwent a second laparotomy followed by BEP chemotherapy. Because of new liver masses, she was treated with paclitaxel, with complete response. Following diagnosis of new liver lesions, third-line chemotherapy with docetaxel was initiated, resulting in stable disease and a PFI of 24 months. Conclusion: Docetaxel might be a good alternative for treating recurrent GCT.


Keywords

Granulosa cell tumor; Docetaxel

Cite and Share

T. Shavit,I. BRUCHIM,Z. Ben-Harim,A. Fishman. Successful response to docetaxel treatment in recurrent ovarian granulosa cell tumor: a case report. European Journal of Gynaecological Oncology. 2012. 33(4);419-420.

References

[1] Colombo N., Parma G., Zanagnolo V., Insinga A.: “Management of ovarian stromal tumors”. J. Clin. Oncol., 2007, 25, 2944.

[2] Gershenson D.M., Copeland L.J., Kavanagh J.J., Stringer C.A., Saul P.B., Wharton J.T.: “Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide”. Obstet. Gynecol., 1987, 70, 765.

[3] Gershenson DM, Morris M, Burke TW., Levenback C., Matthews C.M., Wharton J.T.: “Treatment of poor-prognosis sex cordstromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin”. Obstet. Gynecol., 1996, 87, 527.

[4] Brown J., Shavartsman H.S., Deavers M.T., Burke T.W., Munsell M.F., Gershenson D.M.: “The activity of taxanes in the treatment of sex cord-stromal ovarian tumors”. J. Clin. Oncol., 2004, 22, 3517.

[5] Tresukosol D., Kudelka A.P., Edwards C.L., Charnsangavej C., Narboni N., Kavanagh J.J.: “Recurrent ovarian granulose cell tumor: a case report of a dramatic response to Taxol”. J. Gynecol. Cancer, 1995, 5, 156.

[6] Powell J.L., Connor G.P., Henderson G.S.: “Management of recurrent juvenile granulosa cell tumor of the ovary”. Gynecol. Oncol., 2001, 81, 113.

[7] Francis P., Schneider J., Hann L., Balmaceda C., Barakat R., Phillips M. et al.: “Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer”. J. Clin. Oncol., 1994, 12, 2301.

[8] Vasey P.A., Jayson G.C., Gordon A., Gabra H., Coleman R., Atkinson R. et al.: “Phase III randomized trial of docetaxel-carboplatin versus paclitacel-carboplatin as first-line chemotherapy for ovarian carcinoma”. J. Nation Cancer Instit., 2004, 96, 1682.

[9] Homesley H.D., Bundy B.N., Hurteau J.A., Roth L.M.: “Bleomycin, etoposide, and cisplatin combination chemotherapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study”. Gynecol. Oncol., 1999, 72, 131.

[10] Brown J., Shvartsman H.S., Deavers M., Ramondetta L.M., Burke T.W., Munsell M.F., Gershenson D.M.: “The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors”. Gynecol. Oncol., 2005, 97, 489.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top